Page last updated: 2024-09-03

ly 274614 and amphetamine

ly 274614 has been researched along with amphetamine in 1 studies

Compound Research Comparison

Studies
(ly 274614)
Trials
(ly 274614)
Recent Studies (post-2010)
(ly 274614)
Studies
(amphetamine)
Trials
(amphetamine)
Recent Studies (post-2010) (amphetamine)
9601513,0713291,977

Protein Interaction Comparison

ProteinTaxonomyly 274614 (IC50)amphetamine (IC50)
Phenylethanolamine N-methyltransferaseBos taurus (cattle)0.96
Cytochrome P450 2A6Homo sapiens (human)3.5
Cytochrome P450 2A5Mus musculus (house mouse)2.85
Sodium-dependent dopamine transporterRattus norvegicus (Norway rat)0.96
Beta-2 adrenergic receptorCavia porcellus (domestic guinea pig)0.96

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fuller, RW; Hemrick-Luecke, SK; Ornstein, PL1

Other Studies

1 other study(ies) available for ly 274614 and amphetamine

ArticleYear
Protection against amphetamine-induced neurotoxicity toward striatal dopamine neurons in rodents by LY274614, an excitatory amino acid antagonist.
    Neuropharmacology, 1992, Volume: 31, Issue:10

    Topics: Amino Acids; Amphetamine; Animals; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Iprindole; Isoquinolines; Male; Methamphetamine; Mice; Nervous System Diseases; Neurons; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate

1992